SLS
NasdaqCMSELLAS Life Sciences Group, Inc.
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 10 recent filings. None are open-market buys/sells — recent activity is grants, option exercises, gifts or tax withholding (which don't signal conviction).
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Stergiou Angelos M. Director, President and CEO | Grant / award | 1.07M | $0.00 | — | 2026-06-16 |
Varian John Director | Grant / award | 50K | $0.00 | — | 2026-01-07 |
VAN NOSTRAND ROBERT L Director | Grant / award | 50K | $0.00 | — | 2026-01-07 |
SCHEINBERG DAVID A Director | Grant / award | 50K | $0.00 | — | 2026-01-07 |
CICIC DRAGAN SVP, Chief Development Officer | Grant / award | 300K | $0.00 | — | 2026-01-07 |
Burns John Thomas CFO | Grant / award | 300K | $0.00 | — | 2026-01-07 |
Kalin Katherine Bach Director | Grant / award | 50K | $0.00 | — | 2026-01-07 |
Wasman Jane Director | Grant / award | 50K | $0.00 | — | 2026-01-07 |
CICIC DRAGAN SVP, Chief Development Officer | Code J | 63.8K | $1.50 | $95,700.00 | 2025-12-03 |
Burns John Thomas CFO | Code J | 58.59K | $1.50 | $87,888.00 | 2025-12-03 |
Source: SEC EDGAR Forms 4/4A (CIK 1390478). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$SLS
@bretfish Ok, that fine. Curious, do you know what the schedule was for those employee shares? Any language what happens to them in the case of a Buyout? $SLS
$SLS
$SLS
@StrategicMoose "At least as good". Hmmm, now I'm a bit more convinced that you're starting to doubt yourself. Pumpers remorse. $SLS
@StrategicMoose Nice desperate encouragement note at the end, but the damage was done. Not sure who the "other" random bio(s) are, but I'd say it sounds like you're spooked by them. $SLS
@StrategicMoose And curious, have you looked at the analyst write-ups on $SLS? You know, the ones that assign a PT. Do they miss SLS009 altogether?
$SLS Folks. This is the definition of computer ALGO driven trading. Working with market makers. Only works in certain liquidity periods. We will see how well it works at the end of the week…
@StrategicMoose And no one have forgotten about SLS009. It's part of the picture and package for $SLS.
$SLS
@StockGuru7676 Absolutely misperception…look at my profile, it’s always all-caps ‘round here—not to be misunderstood as loud, aggressive, or otherwise of the ilk…that’s on you; I’m good, man, assuredly, I just don’t have any tolerance for people inaccurately judging people, nor those getting a rise out of despairing projection—and as much as I agree with your sentiments regarding the derivation of “wealth” in life, you’d be a charlatan when the equation over there is what it is; you’re an egoist, somewhat tempered, albeit ego-driven to state what you do, then placate yourself by diluting your brashness. $SLS
@StrategicMoose Interesting choice of words..."LITIGATING" the success of GPS/REGAL...Kinds seems like the theme regarding $SLS these days...
Latest news
Will Near-Complete REGAL Phase 3 GPS Data and New Executive Terms Change SELLAS Life Sciences Group's (SLS) Narrative
SELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On Returns
SELLAS Life Sciences Group (SLS) Stock Pricey Following Phase 3 Trial Buzz
Sellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial Result
SLS Stock Hits July Low As AML Readout Nears — Retail Bulls See ‘Stellar’ Hint In CEO’s Fox Appearance Next Week
SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot
SLS Stock Jumps Overnight After New Investor Disclosure – Retail Flags ‘Massive’ Options Bet Ahead Of AML Data
SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears
Here’s Why SELLAS (SLS) is Among the 10 Best Performing American Stocks in June 2026
SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.